Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Health Secur ; 19(5): 498-507, 2021.
Article in English | MEDLINE | ID: mdl-34495744

ABSTRACT

National public health institutes (NPHIs)-science-based governmental agencies typically part of, or closely aligned with, ministries of health-have played a critical part in many countries' responses to the COVID-19 pandemic. Through listening sessions with NPHI leadership, we captured the experiences of NPHIs in Africa. Our research was further supplemented by a review of the literature. To address issues related to COVID-19, NPHIs in Africa developed a variety of innovative approaches, such as working with the private sector to procure and manage vital supplies and address key information needs. Creative uses of technology, including virtual training and messaging from drones, contributed to sharing information and battling misinformation. Positive impacts of the pandemic response include increased laboratory capacity in many countries, modernized surveillance systems, and strengthened public-private partnerships; much of this enhanced capacity is expected to persist beyond the pandemic. However, several challenges remain, including the lack of staff trained in areas like bioinformatics (essential for genomic analysis) and the need for sustained relationships and data sharing between NPHIs and agencies not traditionally considered public health (eg, those related to border crossings), as well as the impact of the pandemic on prevention and control of non-COVID-19 conditions-both infectious and noncommunicable. Participants in the listening sessions also highlighted concerns about inequities in access to, and quality of, the public health services and clinical care with resultant disproportionate impact of the pandemic on certain populations. COVID-19 responses and challenges highlight the need for continued investment to strengthen NPHIs and public health infrastructure to address longstanding deficiencies and ensure preparedness for the next public health crisis.


Subject(s)
COVID-19 , Public Health , Africa/epidemiology , Humans , Information Dissemination , Pandemics/prevention & control , SARS-CoV-2
2.
Health Secur ; 18(S1): S43-S52, 2020 Jan.
Article in English | MEDLINE | ID: mdl-32004123

ABSTRACT

As countries face public health emergencies, building public health capacity to prevent, detect, and respond to threats is a priority. In recent years, national public health institutes (NPHIs) have emerged to play a critical role in strengthening public health systems and to accelerate and achieve implementation of the International Health Regulations (IHR 2005). NPHIs are science-based government institutions that provide national leadership and expertise for the country's efforts to protect and improve health. Providing a Legal Framework for a National Public Health Institute is a recently released Africa CDC publication intended to support NPHI development throughout Africa. Here we present a legal mapping analysis of sampled legal domains for 5 countries, using the "Menu of Considerations for an NPHI Legal Framework." The analysis delineates the types of legal authorities countries may use to establish or enhance NPHIs and demonstrates how legal mapping can be used to review legal instruments for NPHIs. It also demonstrates variability among legal approaches countries take to establish and enable public health functions for NPHIs. This article examines how the legal framework and menu of considerations can help countries understand the nuances around creating and implementing the laws that will govern their organizations and how countries can better engage stakeholders to identify or address potential areas for opportunity where law may be used as a tool to strengthen public health infrastructure.


Subject(s)
Public Health Administration/legislation & jurisprudence , Africa , Capacity Building/legislation & jurisprudence , Humans , Public Health/legislation & jurisprudence
3.
J Am Assoc Lab Anim Sci ; 52(6): 725-31, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24351760

ABSTRACT

Little is known about the prevalence of zoonotic infections among laboratory animal care technicians (LAT). Q fever, a disease caused by Coxiella burnetii, is a known occupational hazard for persons caring for livestock. We sought to determine the seroprevalence of C. burnetii antibodies among LAT and to identify risk factors associated with C. burnetii seropositivity. A survey was administered and serum samples collected from a convenience sample of 97 LAT. Samples were screened by using a Q fever IgG ELISA. Immunofluorescent antibody assays for phase I and phase II IgG were used to confirm the status of samples that were positive or equivocal by ELISA; positive samples were titered to endpoint. Antibodies against C. burnetii were detected in 6 (6%) of the 97 respondents. In our sample of LAT, seropositivity to C. burnetii was therefore twice as high in LAT as compared with the general population. Age, sex, and working with sheep regularly were not associated with seropositivity. Risk factors associated with seropositivity included breeding cattle within respondent's research facility, any current job contact with waste from beef cattle or goats, and exposure to animal waste during previous jobs or outside of current job duties. Only 15% of responding LAT reported being aware that sheep, goats, and cattle can transmit Q fever. Research facilities that use cattle or goats should evaluate their waste-management practices and educational programs in light of these findings. Additional efforts are needed to increase awareness among LAT regarding Q fever and heightened risk of exposure to infectious materials. Physicians should consider the risk of infection with C. burnetii when treating LAT with potential occupational exposures.


Subject(s)
Animal Technicians , Antibodies, Bacterial/blood , Coxiella burnetii , Occupational Exposure , Q Fever/epidemiology , Adult , Animals , Female , Humans , Male , Middle Aged , Q Fever/diagnosis , Q Fever/prevention & control , Risk Factors , Seroepidemiologic Studies , United States , Young Adult , Zoonoses/diagnosis , Zoonoses/epidemiology , Zoonoses/prevention & control
4.
J Am Vet Med Assoc ; 234(7): 938-44, 2009 Apr 01.
Article in English | MEDLINE | ID: mdl-19335247

ABSTRACT

OBJECTIVE: To determine the seroprevalence of antibodies against Leptospira serovars among veterinarians and identify risk factors for seropositivity in veterinary care settings. DESIGN: Seroepidemiologic survey. STUDY POPULATION: Veterinarians attending the 2006 AVMA Annual Convention. PROCEDURES: Blood samples were collected from 511 veterinarians, and serum was harvested for a microcapsule agglutination test (MAT) to detect antibodies against 6 serovars of Leptospira. Aggregate data analysis was performed to determine the ratio of the odds of a given exposure (eg, types of animals treated or biosafety practices) in seropositive individuals to the odds in seronegative individuals. RESULTS: Evidence of previous leptospiral infection was detected in 2.5% of veterinarians. Most veterinarians reported multiple potential exposures to Leptospira spp and other pathogens in the previous 12 months, including unintentional needlestick injuries (379/511 [74.2%]), animal bites (345/511 [67.5%]), and animal scratches (451/511 [88.3%]). Treatment of a dog with an influenza-like illness within the past year was associated with seropositivity for antibodies against Leptospira spp. CONCLUSIONS AND CLINICAL RELEVANCE: Veterinarians are at risk for leptospirosis and should take measures to decrease potential exposure to infectious agents in general. Diagnostic tests for leptospirosis should be considered when veterinarians have febrile illnesses of unknown origin.


Subject(s)
Antibodies, Bacterial/blood , Leptospira/immunology , Leptospirosis/epidemiology , Occupational Diseases/epidemiology , Veterinarians , Adult , Animals , Animals, Domestic , Diagnosis, Differential , Female , Humans , Leptospirosis/transmission , Leptospirosis/veterinary , Male , Middle Aged , Occupational Exposure , Prevalence , Risk Factors , Seroepidemiologic Studies , United States/epidemiology
5.
Vector Borne Zoonotic Dis ; 6(1): 42-9, 2006.
Article in English | MEDLINE | ID: mdl-16584326

ABSTRACT

In Georgia, most individuals reported with West Nile virus (WNV) disease have been diagnosed with West Nile neuroinvasive disease (WNND). Relatively few cases of West Nile Fever (WNF) are reported, and the burden of illness due to WNV is likely underestimated. From July through October 2003, WNV serologic testing was performed on enrolled patients>or=18 years of age with fever admitted to a large, urban hospital in Atlanta, Georgia through the emergency department (ED). Patients' history, clinical, and laboratory data were recorded. Residual blood drawn in the ED was tested to determine the presence of WNV IgG and IgM antibodies. Of 254 patients tested for WNV, four (1.6%) patients were positive for WNV IgM and IgG antibodies, and had a clinical illness compatible with WNV. None of the four positive patients were clinically suspected of having WNV infection; discharge diagnoses included pneumonia, migraine, stroke, and gout. These four patients accounted for 80% of all WNV diagnosed in this hospital, 44% of all cases in Fulton County, and 7% of all cases reported in Georgia in 2003. The occurrence of WNV disease may be substantially greater than currently reflected in disease statistics in Georgia and many other states. When indicators of WNV activity are present and patients are likely to have had intensive mosquito exposure, WNV should be considered in the differential diagnosis of seriously ill, febrile patients.


Subject(s)
West Nile Fever/diagnosis , West Nile Fever/epidemiology , West Nile virus/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Diagnostic Tests, Routine/standards , Female , Fever/virology , Georgia/epidemiology , Hospitalization , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Middle Aged , Population Surveillance/methods , Time Factors , West Nile Fever/immunology , West Nile Fever/virology , West Nile virus/immunology
6.
Emerg Infect Dis ; 9(6): 651-656, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12780997

ABSTRACT

Because of the emergence of Buruli ulcer disease, the World Health Organization launched a Global Buruli Ulcer Initiative in 1998. This indolent skin infection is caused by Mycobacterium ulcerans. During a study of risk factors for the disease in Ghana, adequate excisional skin-biopsy specimens were obtained from 124 clinically suspicious lesions. Buruli ulcer disease was diagnosed in 78 lesions since acid-fast bacilli (AFB) were found by histopathologic examination. Lesions with other diagnoses included filariasis (3 cases), zygomycosis (2 cases), ulcerative squamous cell carcinomas (2 cases), keratin cyst (1 case), and lymph node (1 case). Thirty-seven specimens that did not show AFB were considered suspected Buruli ulcer disease cases. Necrosis of subcutaneous tissues and dermal collagen were found more frequently in AFB-positive specimens compared with specimens from suspected case-patients (p<0.001). Defining histologic criteria for a diagnosis of Buruli ulcer disease is of clinical and public health importance since it would allow earlier treatment, leading to less deforming sequelae.


Subject(s)
Mycobacterium Infections, Nontuberculous/pathology , Mycobacterium ulcerans/isolation & purification , Skin Diseases, Bacterial/pathology , Skin Ulcer/pathology , DNA, Bacterial/analysis , Diagnosis, Differential , Humans , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/surgery , Necrosis , Polymerase Chain Reaction/methods , Skin/pathology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/surgery , Skin Ulcer/diagnosis , Skin Ulcer/microbiology , Staining and Labeling
7.
Emerg Infect Dis ; 8(12): 1455-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12498663

ABSTRACT

After an outbreak of leptospirosis in workers who participated in cleaning a pond during September 1999 in Thailand, a serologic survey was conducted. Among a cohort of 104 persons from one village who participated in pond cleaning activity, 43 (41.3%) were seropositive for immunoglobulin M antibodies against Leptospira, indicating recent infection. Only 17 (39.5%) of 43 seropositive persons reported a recent febrile illness; the remaining seropositive persons were considered asymptomatic, suggesting that asymptomatic leptospirosis infection may be common where leptospirosis is endemic. Multivariable logistic regression indicated that wearing long pants or skirts was independently protective against leptospirosis infection (OR(adjusted) = 0.217), while the presence of more than two wounds on the body was independently associated with infection (OR(adjusted) = 3.97). Educational efforts should be enhanced in areas where leptospirosis is endemic to encourage the use of protective clothing. In addition, wound management and avoidance of potentially contaminated water when skin wounds are present should be included in health education programs.


Subject(s)
Disease Outbreaks , Leptospirosis/epidemiology , Occupational Exposure , Skin/injuries , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Leptospirosis/etiology , Leptospirosis/prevention & control , Logistic Models , Male , Middle Aged , Prevalence , Risk Factors , Skin/microbiology , Thailand/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...